Back
Laboratorios Farmaceuticos Rovi SA 10K Form
Buy
74
LABFF
Laboratorios Farmaceuticos Rovi SA
Last Price:
90.61
Seasonality Move:
0%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LABFF News And Ratings
See the #1 stock for the next 7 days that we like better than LABFF
LABFF Financial Statistics
Sales & Book Value
| Annual Sales: | $898.03M |
|---|---|
| Cash Flow: | $22.53M |
| Price / Cash Flow: | 66.84 |
| Annual Sales: | $9.98 |
| Price / Book: | 9.08 |
Profitability
| EPS (TTM): | 3.49240 |
|---|---|
| Net Income (TTM): | $179.41M |
| Gross Margin: | $532.95M |
| Return on Equity: | 28.24% |
| Return on Assets: | 20.37% |
Laboratorios Farmaceuticos Rovi SA Earnings Forecast
Key Laboratorios Farmaceuticos Rovi SA Financial Ratios
- The Gross Profit Margin over the past 18 years for LABFF is 59.35%.
- The Selling, General & Administrative Expenses for LABFF have been equal to 4.58% of Gross Profit Margin.
- The Interest Expense is 0.39% of Operating Income.
- The Net Earning history of LABFF is 20.53% of Total Revenues.
- Per Share Earnings over the last 18 years have been positive in 11 years.
Laboratorios Farmaceuticos Rovi SA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | LABFF |
| Website: | rovi.es |
Debt
| Debt-to-Equity Ratio: | 0.25 |
|---|---|
| Current Ratio: | 1.98 |
| Quick Ratio: | 0.67 |
Price-to-Earnings
| Trailing P/E Ratio: | 26.16 |
|---|---|
| Forward P/E Ratio: | 0 |
LABFF Technical Analysis vs Fundamental Analysis
Buy
74
Laboratorios Farmaceuticos Rovi SA (LABFF)
is a Buy
Is Laboratorios Farmaceuticos Rovi SA a Buy or a Sell?
-
Laboratorios Farmaceuticos Rovi SA stock is rated a Buy
The current Laboratorios Farmaceuticos Rovi SA [LABFF] share price is $90.61. The Score for LABFF is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.